GAO December, 2019

Report to Congressional Requesters

Benefits and Challenges of Machine Learning in Drug Development

With field background content from the National Academy of Medicine

Foreword

The U.S. health care system is at an important crossroads as it faces major demographic shifts, burgeoning costs, and transformative technologies. Although the growth in health care costs has moderated recently, total annual health care spending in the United States is projected to reach nearly $6 trillion by 2027. Federal spending for health care programs—which accounts for more than a quarter of all health care spending—has grown faster than the overall economy in recent years, a trend projected to continue. Every day more than 10,000 Americans turn age 65, becoming eligible for Medicare. These demographic realities...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), GAO, Govt Agencies, Market Research, Pharma, Technology, Trends
Digital Innovation Plus AI Tech Can Future-Proof the Enterprise
The AI frenzy could fall flat as companies hoard chips without enough data centers to host them
New AI drug discovery powerhouse Xaira rises with $1B in funding
EU regulation: AI Act will mean a raft of new requirements for ‘high-risk’ systems
Why nurses are protesting AI

Share This Article